Position in MRK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$44,209,341
+$5,164,618 QoQ
Shares Held
367,523
-0.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
2.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. MRK ranks #2 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
|
13,439 | $377,367 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,209,341 | 367,523 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $39,044,723 | 370,936 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $19,180,271 | 228,527 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $28,121,431 | 355,248 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $30,629,253 | 341,235 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $32,827,504 | 329,991 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $37,661,265 | 331,642 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $41,505,435 | 335,262 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $44,219,084 | 335,120 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $36,384,661 | 333,743 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $33,903,699 | 329,322 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $38,823,311 | 336,453 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $35,155,086 | 330,436 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $39,973,066 | 360,280 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $31,235,637 | 362,699 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $32,623,087 | 357,827 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $29,208,076 | 355,979 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $26,820,244 | 349,951 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $25,728,630 | 342,546 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $25,202,301 | 324,062 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $24,121,011 | 312,894 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $24,258,760 | 296,562 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $24,167,742 | 291,353 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $22,578,204 | 291,972 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $22,666,437 | 294,599 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||